标题
Therapeutic in vivo delivery of gene editing agents
作者
关键词
-
出版物
CELL
Volume 185, Issue 15, Pages 2806-2827
出版商
Elsevier BV
发表日期
2022-07-06
DOI
10.1016/j.cell.2022.03.045
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins
- (2022) Samagya Banskota et al. CELL
- Delivery of CRISPR-Cas tools for in vivo genome editing therapy: Trends and challenges
- (2022) Eman A. Taha et al. JOURNAL OF CONTROLLED RELEASE
- CRISPR-based genome editing through the lens of DNA repair
- (2022) Tarun S. Nambiar et al. MOLECULAR CELL
- A flexible split prime editor using truncated reverse transcriptase improves dual-AAV delivery in mouse liver
- (2022) Chunwei Zheng et al. MOLECULAR THERAPY
- CAR T cells produced in vivo to treat cardiac injury
- (2022) Joel G. Rurik et al. SCIENCE
- Nuclear and mitochondrial DNA editing in human cells with zinc finger deaminases
- (2022) Kayeong Lim et al. Nature Communications
- In vivo mitochondrial base editing via adeno-associated viral delivery to mouse post-mitotic tissue
- (2022) Pedro Silva-Pinheiro et al. Nature Communications
- Targeted A-to-G base editing in human mitochondrial DNA with programmable deaminases
- (2022) Sung-Ik Cho et al. CELL
- A split prime editor with untethered reverse transcriptase and circular RNA template
- (2022) Bin Liu et al. NATURE BIOTECHNOLOGY
- In vivo prime editing of a metabolic liver disease in mice
- (2022) Desirée Böck et al. Science Translational Medicine
- In vivo base editing rescues Hutchinson–Gilford progeria syndrome in mice
- (2021) Luke W. Koblan et al. NATURE
- Targeting herpes simplex virus with CRISPR–Cas9 cures herpetic stromal keratitis in mice
- (2021) Di Yin et al. NATURE BIOTECHNOLOGY
- The clinical landscape for AAV gene therapies
- (2021) Dmitry A. Kuzmin et al. NATURE REVIEWS DRUG DISCOVERY
- Efficient and high-fidelity base editor with expanded PAM compatibility for cytidine dinucleotide
- (2021) Zhiquan Liu et al. Science China-Life Sciences
- In vivo cytidine base editing of hepatocytes without detectable off-target mutations in RNA and DNA
- (2021) Lukas Villiger et al. Nature Biomedical Engineering
- Lentiviral delivery of co-packaged Cas9 mRNA and a Vegfa-targeting guide RNA prevents wet age-related macular degeneration in mice
- (2021) Sikai Ling et al. Nature Biomedical Engineering
- Quantitative evaluation of chromosomal rearrangements in gene-edited human stem cells by CAST-Seq
- (2021) Giandomenico Turchiano et al. Cell Stem Cell
- Cas9-directed immune tolerance in humans—a model to evaluate regulatory T cells in gene therapy?
- (2021) Dimitrios Laurin Wagner et al. GENE THERAPY
- Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3
- (2021) Min Qiu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mitochondrial DNA editing in mice with DddA-TALE fusion deaminases
- (2021) Hyunji Lee et al. Nature Communications
- Programmable C:G to G:C genome editing with CRISPR-Cas9-directed base excision repair proteins
- (2021) Liwei Chen et al. Nature Communications
- Adenine Base Editor Ribonucleoproteins Delivered by Lentivirus-Like Particles Show High On-Target Base Editing and Undetectable RNA Off-Target Activities
- (2021) Pin Lyu et al. CRISPR Journal
- In vivo HSPC gene therapy with base editors allows for efficient reactivation of fetal γ-globin in β-YAC mice
- (2021) Chang Li et al. Blood Advances
- mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability
- (2021) Linde Schoenmaker et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates
- (2021) Kiran Musunuru et al. NATURE
- The NIH Somatic Cell Genome Editing program
- (2021) Krishanu Saha et al. NATURE
- In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels
- (2021) Tanja Rothgangl et al. NATURE BIOTECHNOLOGY
- Eliminating base-editor-induced genome-wide and transcriptome-wide off-target mutations
- (2021) Lijie Wang et al. NATURE CELL BIOLOGY
- Chromothripsis as an on-target consequence of CRISPR–Cas9 genome editing
- (2021) Mitchell L. Leibowitz et al. NATURE GENETICS
- Improved prime editors enable pathogenic allele correction and cancer modelling in adult mice
- (2021) Pengpeng Liu et al. Nature Communications
- Anti-AAV Antibodies in AAV Gene Therapy: Current Challenges and Possible Solutions
- (2021) Thomas Weber Frontiers in Immunology
- Precise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing
- (2021) F. Chemello et al. Science Advances
- Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species
- (2021) Mohammadsharif Tabebordbar et al. CELL
- In vivo somatic cell base editing and prime editing
- (2021) Gregory A. Newby et al. MOLECULAR THERAPY
- Base editing of haematopoietic stem cells rescues sickle cell disease in mice
- (2021) Gregory A. Newby et al. NATURE
- Efficient C•G-to-G•C base editors developed using CRISPRi screens, target-library analysis, and machine learning
- (2021) Luke W. Koblan et al. NATURE BIOTECHNOLOGY
- CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
- (2021) Julian D. Gillmore et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mammalian retrovirus-like protein PEG10 packages its own mRNA and can be pseudotyped for mRNA delivery
- (2021) Michael Segel et al. SCIENCE
- Efficient precise in vivo base editing in adult dystrophic mice
- (2021) Li Xu et al. Nature Communications
- Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering
- (2021) Jennifer R. Hamilton et al. Cell Reports
- The impact of lentiviral vector genome size and producer cell genomic to gag-pol mRNA ratios on packaging efficiency and titre
- (2021) Nathan P. Sweeney et al. Molecular Therapy-Methods & Clinical Development
- High-purity production and precise editing of DNA base editing ribonucleoproteins
- (2021) Hyeon-Ki Jang et al. Science Advances
- Enhanced prime editing systems by manipulating cellular determinants of editing outcomes
- (2021) Peter J. Chen et al. CELL
- CRISPR-derived genome editing therapies: Progress from bench to bedside
- (2021) Holly A. Rees et al. MOLECULAR THERAPY
- Engineered pegRNAs improve prime editing efficiency
- (2021) James W. Nelson et al. NATURE BIOTECHNOLOGY
- AAV capsid variants with brain-wide transgene expression and decreased liver targeting after intravenous delivery in mouse and marmoset
- (2021) David Goertsen et al. NATURE NEUROSCIENCE
- On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles
- (2021) Sean A. Dilliard et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice
- (2021) Eriya Kenjo et al. Nature Communications
- Comprehensive deletion landscape of CRISPR-Cas9 identifies minimal RNA-guided DNA-binding modules
- (2021) Arik Shams et al. Nature Communications
- Self-inactivating, all-in-one AAV vectors for precision Cas9 genome editing via homology-directed repair in vivo
- (2021) Raed Ibraheim et al. Nature Communications
- DdCBE mediates efficient and inheritable modifications in mouse mitochondrial genome
- (2021) Jiayin Guo et al. Molecular Therapy-Nucleic Acids
- Can Adeno-Associated Viral Vectors Deliver Effectively Large Genes?
- (2020) Patrizia Tornabene et al. HUMAN GENE THERAPY
- Treatment of a Mouse Model of ALS by In Vivo Base Editing
- (2020) Colin K.W. Lim et al. MOLECULAR THERAPY
- AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer
- (2020) Helena Costa Verdera et al. MOLECULAR THERAPY
- The promise and challenge of therapeutic genome editing
- (2020) Jennifer A. Doudna NATURE
- Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors
- (2020) Jordan L. Doman et al. NATURE BIOTECHNOLOGY
- Programmable base editing of mutated TERT promoter inhibits brain tumour growth
- (2020) Xinjian Li et al. NATURE CELL BIOLOGY
- CRISPR-engineered T cells in patients with refractory cancer
- (2020) Edward A. Stadtmauer et al. SCIENCE
- Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses
- (2020) Jonathan M. Levy et al. Nature Biomedical Engineering
- CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors
- (2020) Dan Wang et al. CELL
- Directed evolution of adenine base editors with increased activity and therapeutic application
- (2020) Nicole M. Gaudelli et al. NATURE BIOTECHNOLOGY
- Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity
- (2020) Michelle F. Richter et al. NATURE BIOTECHNOLOGY
- Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing
- (2020) Qiang Cheng et al. Nature Nanotechnology
- Chemical modifications of adenine base editor mRNA and guide RNA expand its application scope
- (2020) Tingting Jiang et al. Nature Communications
- Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping
- (2020) Peter Gee et al. Nature Communications
- A compact Cas9 ortholog from Staphylococcus Auricularis (SauriCas9) expands the DNA targeting scope
- (2020) Ziying Hu et al. PLOS BIOLOGY
- Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for In Vivo CRISPR/Cas-Based Genome Editing
- (2020) Tuo Wei et al. ACS Nano
- Lipid nanoparticle technology for therapeutic gene regulation in the liver
- (2020) Dominik Witzigmann et al. ADVANCED DRUG DELIVERY REVIEWS
- A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing
- (2020) Beverly Y. Mok et al. NATURE
- Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
- (2020) Andrew V. Anzalone et al. NATURE BIOTECHNOLOGY
- CRISPR C-to-G base editors for inducing targeted DNA transversions in human cells
- (2020) Ibrahim C. Kurt et al. NATURE BIOTECHNOLOGY
- The delivery challenge: fulfilling the promise of therapeutic genome editing
- (2020) Joost van Haasteren et al. NATURE BIOTECHNOLOGY
- Highly efficient ‘hit-and-run’ genome editing with unconcentrated lentivectors carrying Vpr.Prot.Cas9 protein produced from RRE-containing transcripts
- (2020) Ivana Indikova et al. NUCLEIC ACIDS RESEARCH
- In vivo base editing restores sensory transduction and transiently improves auditory function in a mouse model of recessive deafness
- (2020) Wei-Hsi Yeh et al. Science Translational Medicine
- Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing
- (2020) Tuo Wei et al. Nature Communications
- In vivo–directed evolution of adeno-associated virus in the primate retina
- (2020) Leah C. Byrne et al. JCI Insight
- Development of Highly Efficient Dual‐AAV Split Adenosine Base Editor for In Vivo Gene Therapy
- (2020) Yuxi Chen et al. Small Methods
- Endocytosis in cellular uptake of drug delivery vectors: Molecular aspects in drug development
- (2020) Zuzanna Kaźmierczak et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Large-Fragment Deletions Induced by Cas9 Cleavage while Not in the BEs System
- (2020) Yuning Song et al. Molecular Therapy-Nucleic Acids
- Restoration of visual function in adult mice with an inherited retinal disease via adenine base editing
- (2020) Susie Suh et al. Nature Biomedical Engineering
- Current Clinical Applications of In Vivo Gene Therapy with AAVs
- (2020) Jerry R. Mendell et al. MOLECULAR THERAPY
- Engineering precision nanoparticles for drug delivery
- (2020) Michael J. Mitchell et al. NATURE REVIEWS DRUG DISCOVERY
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- In Vivo Gene Editing of Muscle Stem Cells with Adeno-Associated Viral Vectors in a Mouse Model of Duchenne Muscular Dystrophy
- (2020) Jennifer B. Kwon et al. Molecular Therapy-Methods & Clinical Development
- Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10
- (2019) Morgan L. Maeder et al. NATURE MEDICINE
- Delivering SaCas9 mRNA by lentivirus-like bionanoparticles for transient expression and efficient genome editing
- (2019) Baisong Lu et al. NUCLEIC ACIDS RESEARCH
- Adeno-associated virus vector as a platform for gene therapy delivery
- (2019) Dan Wang et al. NATURE REVIEWS DRUG DISCOVERY
- Identification of preexisting adaptive immunity to Cas9 proteins in humans
- (2019) Carsten T. Charlesworth et al. NATURE MEDICINE
- Adopt a moratorium on heritable genome editing
- (2019) Eric S. Lander et al. NATURE
- Cell-specific CRISPR–Cas9 activation by microRNA-dependent expression of anti-CRISPR proteins
- (2019) Mareike D Hoffmann et al. NUCLEIC ACIDS RESEARCH
- Fast and Efficient CRISPR/Cas9 Genome Editing In Vivo Enabled by Bioreducible Lipid and Messenger RNA Nanoparticles
- (2019) Ji Liu et al. ADVANCED MATERIALS
- AAV9 Edits Muscle Stem Cells in Normal and Dystrophic Adult Mice
- (2019) Michael E. Nance et al. MOLECULAR THERAPY
- Delivering Cas9/sgRNA ribonucleoprotein (RNP) by lentiviral capsid-based bionanoparticles for efficient ‘hit-and-run’ genome editing
- (2019) Pin Lyu et al. NUCLEIC ACIDS RESEARCH
- Utility of self-destructing CRISPR/Cas constructs for targeted gene editing in the retina
- (2019) Fan Li et al. HUMAN GENE THERAPY
- Tissue-restricted Genome Editing in vivo Specified by MicroRNA-repressible Anti-CRISPR Proteins
- (2019) Jooyoung Lee et al. RNA
- Search-and-replace genome editing without double-strand breaks or donor DNA
- (2019) Andrew V. Anzalone et al. NATURE
- Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors
- (2019) Beau R. Webber et al. Nature Communications
- The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
- (2019) Akin Akinc et al. Nature Nanotechnology
- UDiTaS™, a genome editing detection method for indels and genome rearrangements
- (2018) Georgia Giannoukos et al. BMC GENOMICS
- Gene therapy clinical trials worldwide to 2017: An update
- (2018) Samantha L. Ginn et al. JOURNAL OF GENE MEDICINE
- Clinical use of lentiviral vectors
- (2018) Michael C. Milone et al. LEUKEMIA
- Microhomology-mediated end joining: Good, bad and ugly
- (2018) Ja-Hwan Seol et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy
- (2018) Seuk-Min Ryu et al. NATURE BIOTECHNOLOGY
- Repair of double-strand breaks induced by CRISPR–Cas9 leads to large deletions and complex rearrangements
- (2018) Michael Kosicki et al. NATURE BIOTECHNOLOGY
- A modular platform for targeted RNAi therapeutics
- (2018) Ranit Kedmi et al. Nature Nanotechnology
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- In vivo base editing of post-mitotic sensory cells
- (2018) Wei-Hsi Yeh et al. Nature Communications
- A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing
- (2018) Jonathan D. Finn et al. Cell Reports
- Viral escape from endosomes and host detection at a glance
- (2018) Jacqueline Staring et al. JOURNAL OF CELL SCIENCE
- Gene therapy for neurological disorders: progress and prospects
- (2018) Benjamin E. Deverman et al. NATURE REVIEWS DRUG DISCOVERY
- Cas9 immunity creates challenges for CRISPR gene editing therapies
- (2018) Julie M. Crudele et al. Nature Communications
- Improved Lentiviral Gene Delivery to Mouse Liver by Hydrodynamic Vector Injection through Tail Vein
- (2018) Trine Dalsgaard et al. Molecular Therapy-Nucleic Acids
- Transient retrovirus-based CRISPR/Cas9 all-in-one particles for efficient, targeted gene knockout
- (2018) Yvonne Knopp et al. Molecular Therapy-Nucleic Acids
- The Endosomal Escape of Nanoparticles: Toward More Efficient Cellular Delivery
- (2018) Samuel A. Smith et al. BIOCONJUGATE CHEMISTRY
- A Compact, High-Accuracy Cas9 with a Dinucleotide PAM for In Vivo Genome Editing
- (2018) Alireza Edraki et al. MOLECULAR CELL
- Sangamo's landmark genome editing trial gets mixed reception
- (2018) Cormac Sheridan NATURE BIOTECHNOLOGY
- High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population
- (2018) Dimitrios L. Wagner et al. NATURE MEDICINE
- Treatment of a metabolic liver disease by in vivo genome base editing in adult mice
- (2018) Lukas Villiger et al. NATURE MEDICINE
- Base editing: precision chemistry on the genome and transcriptome of living cells
- (2018) Holly A. Rees et al. NATURE REVIEWS GENETICS
- High-throughput in vivo screen of functional mRNA delivery identifies nanoparticles for endothelial cell gene editing
- (2018) Cory D. Sago et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins
- (2018) Philippe E. Mangeot et al. Nature Communications
- Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes
- (2018) Nuphar Veiga et al. Nature Communications
- A Self-Deleting AAV-CRISPR System for In Vivo Genome Editing
- (2018) Ang Li et al. Molecular Therapy-Methods & Clinical Development
- In Vivo Hematopoietic Stem Cell Transduction
- (2017) Maximilian Richter et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Recombinant Adeno-Associated Viral Integration and Genotoxicity: Insights from Animal Models
- (2017) Randy J. Chandler et al. HUMAN GENE THERAPY
- CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington’s disease
- (2017) Su Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65 -mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial
- (2017) Stephen Russell et al. LANCET
- Lipid Nanoparticle Systems for Enabling Gene Therapies
- (2017) Pieter R. Cullis et al. MOLECULAR THERAPY
- Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents
- (2017) Xue Gao et al. NATURE
- Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
- (2017) Nicole M. Gaudelli et al. NATURE
- Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing
- (2017) Hao Yin et al. NATURE BIOTECHNOLOGY
- Delivery technologies for genome editing
- (2017) Hao Yin et al. NATURE REVIEWS DRUG DISCOVERY
- Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
- (2017) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Subretinal Injection: A Review on the Novel Route of Therapeutic Delivery for Vitreoretinal Diseases
- (2017) Yingqian Peng et al. OPHTHALMIC RESEARCH
- Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics
- (2017) James E. Dahlman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni
- (2017) Eunji Kim et al. Nature Communications
- Pseudotyped Lentiviral Vectors: One Vector, Many Guises
- (2017) Alok V. Joglekar et al. Human Gene Therapy Methods
- In vivo genome editing improves motor function and extends survival in a mouse model of ALS
- (2017) Thomas Gaj et al. Science Advances
- Improved base excision repair inhibition and bacteriophage Mu Gam protein yields C:G-to-T:A base editors with higher efficiency and product purity
- (2017) Alexis C. Komor et al. Science Advances
- Non-Viral CRISPR/Cas Gene Editing In Vitro and In Vivo Enabled by Synthetic Nanoparticle Co-Delivery of Cas9 mRNA and sgRNA
- (2016) Jason B. Miller et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Lentivirus pre-packed with Cas9 protein for safer gene editing
- (2016) J G Choi et al. GENE THERAPY
- The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction
- (2016) Nazanin Hoshyar et al. Nanomedicine
- Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
- (2016) Alexis C. Komor et al. NATURE
- Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain
- (2016) Benjamin E Deverman et al. NATURE BIOTECHNOLOGY
- Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo
- (2016) Hao Yin et al. NATURE BIOTECHNOLOGY
- A multifunctional AAV–CRISPR–Cas9 and its host response
- (2016) Wei Leong Chew et al. NATURE METHODS
- Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems
- (2016) K. Nishida et al. SCIENCE
- Engineering Delivery Vehicles for Genome Editing
- (2016) Christopher E. Nelson et al. Annual Review of Chemical and Biomolecular Engineering
- Mitochondrial diseases
- (2016) Gráinne S. Gorman et al. Nature Reviews Disease Primers
- Adenovirus-Mediated Somatic Genome Editing ofPtenby CRISPR/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses
- (2015) Dan Wang et al. HUMAN GENE THERAPY
- Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs
- (2015) Kevin J. Kauffman et al. NANO LETTERS
- In vivo genome editing using Staphylococcus aureus Cas9
- (2015) F. Ann Ran et al. NATURE
- Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition
- (2015) Benjamin P Kleinstiver et al. NATURE BIOTECHNOLOGY
- Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown
- (2015) Anders Wittrup et al. NATURE BIOTECHNOLOGY
- Therapeutic genome editing: prospects and challenges
- (2015) David Benjamin Turitz Cox et al. NATURE MEDICINE
- Development of an intein-mediated split–Cas9 system for gene therapy
- (2015) Dong-Jiunn Jeffery Truong et al. NUCLEIC ACIDS RESEARCH
- In vivo gene editing in dystrophic mouse muscle and muscle stem cells
- (2015) M. Tabebordbar et al. SCIENCE
- The Blood–Brain Barrier
- (2015) Richard Daneman et al. Cold Spring Harbor Perspectives in Biology
- Trans-spliced Cas9 allows cleavage of HBB and CCR5 genes in human cells using compact expression cassettes
- (2015) Eli J. Fine et al. Scientific Reports
- In Silico Reconstruction of the Viral Evolutionary Lineage Yields a Potent Gene Therapy Vector
- (2015) Eric Zinn et al. Cell Reports
- Highly efficient in vitro and in vivo delivery of functional RNAs using new versatile MS2-chimeric retrovirus-like particles
- (2015) Anne Prel et al. Molecular Therapy-Methods & Clinical Development
- Long-Term Episomal Transgene Expression from Mitotically Stable Integration-Deficient Lentiviral Vectors
- (2014) Hanna Kymäläinen et al. HUMAN GENE THERAPY
- Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo
- (2014) John A Zuris et al. NATURE BIOTECHNOLOGY
- Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector
- (2014) Ami M. Kabadi et al. NUCLEIC ACIDS RESEARCH
- Nature's recipe for splitting inteins
- (2014) A. S. Aranko et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Targeted genome editing by lentiviral protein transduction of zinc-finger and TAL-effector nucleases
- (2014) Yujia Cai et al. eLife
- Adeno-associated virus structural biology as a tool in vector development
- (2013) Lauren M Drouin et al. Future Virology
- Engraftment of a Galactose Receptor Footprint onto Adeno-associated Viral Capsids Improves Transduction Efficiency
- (2013) Shen Shen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics
- (2013) Martin A Maier et al. MOLECULAR THERAPY
- Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape
- (2013) Jerome Gilleron et al. NATURE BIOTECHNOLOGY
- In Vivo-Directed Evolution of a New Adeno-Associated Virus for Therapeutic Outer Retinal Gene Delivery from the Vitreous
- (2013) D. Dalkara et al. Science Translational Medicine
- Playing the End Game: DNA Double-Strand Break Repair Pathway Choice
- (2012) J. Ross Chapman et al. MOLECULAR CELL
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- Protein delivery using engineered virus-like particles
- (2011) S. J. Kaczmarczyk et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Mechanism of Double-Strand DNA Break Repair by the Nonhomologous DNA End-Joining Pathway
- (2010) Michael R. Lieber Annual Review of Biochemistry
- Endosomal escape pathways for delivery of biologicals
- (2010) Amir K. Varkouhi et al. JOURNAL OF CONTROLLED RELEASE
- Protein transduction from retroviral Gag precursors
- (2010) Christine Voelkel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Integration-deficient Lentiviral Vectors: A Slow Coming of Age
- (2009) Klaus Wanisch et al. MOLECULAR THERAPY
- Effect of Genome Size on AAV Vector Packaging
- (2009) Zhijian Wu et al. MOLECULAR THERAPY
- Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle
- (2009) Aravind Asokan et al. NATURE BIOTECHNOLOGY
- Mechanism of Eukaryotic Homologous Recombination
- (2008) Joseph San Filippo et al. Annual Review of Biochemistry
- Protein Trans-Splicing as a Means for Viral Vector-Mediated In Vivo Gene Therapy
- (2008) Juan Li et al. HUMAN GENE THERAPY
- Engineering and Selection of Shuffled AAV Genomes: A New Strategy for Producing Targeted Biological Nanoparticles
- (2008) Wuping Li et al. MOLECULAR THERAPY
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
- (2008) Katalin Karikó et al. MOLECULAR THERAPY
- Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
- (2008) Albert M. Maguire et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search